Zabdeno

Ad26.ZEBOV vaccine · Janssen (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zabdeno, covering 2025-03-18 to 2025-05-14. Get the full timeline:

Most recent: EMA Authorised: Zabdeno (recombinant adenovirus type 26 (Ad26) encoding the glycoprotein (GP) of the Ebola virus Zaire (ZEBOV) Mayinga strain) — Janssen-Cilag International N.V.

See pricing